Dicerna Pharmaceuticals, Inc.
Methods and compositions for inhibiting expression of LDHA

Last updated:

Abstract:

This disclosure relates to oligonucleotides, compositions and methods useful for reducing LDHA expression, particularly in hepatocytes.

Status:
Grant
Type:

Utility

Filling date:

12 Oct 2018

Issue date:

29 Mar 2022